• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.25% Nasdaq Up 0.90%

    Soligenix, Inc. (SNGX)

    -OTC BB
    1.09 Up 0.01(0.74%) 3:23PM EST
    Add to Portfolio
    Prev Close:1.08
    Open:1.08
    Bid:N/A
    Ask:N/A
    1y Target Est:5.88
    Beta:4.59
    Next Earnings Date:N/A
    Day's Range:1.02 - 1.14
    52wk Range:0.91 - 2.49
    Volume:21,312
    Avg Vol (3m):74,750
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNGX

    Comparison

    Symbol% ChgMkt Cap
    SNGXUp 0.74%N/A
    AVNR 0.00%N/A
    CLDXDown 1.49%1.97B
    SNYUp 1.68%122.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.67
    Quarterly EPS Est (Dec-14) :-0.06
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-1.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Soligenix, Inc., a clinical stage biopharmaceutical company, is engaged in developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and various biodefense vaccines and therapeutics. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback